$1.15
-0.03[-2.54%]
At close: Apr 26
Protalix BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Protalix BioTherapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/10/2024 | AM | PLX | Q1 | -$0.05 | -$0.02 | — | — | $9.59M | $9.20M | — | — | Get Alert |
03/14/2024 | AM | PLX | Q4 | -$0.07 | -$0.03 | -$0.07 | -133.33% | $8.62M | $5.80M | $10.49M | 80.79% | Get Alert |
11/06/2023 | AM | PLX | Q3 | -$0.07 | -$0.04 | -$0.04 | 0.00% | $14.18M | $10.00M | $10.35M | 3.45% | Get Alert |
08/07/2023 | AM | PLX | Q2 | -$0.11 | -$0.04 | $0.21 | 625.00% | $8.75M | $10.22M | $35.08M | 243.20% | Get Alert |
05/04/2023 | AM | PLX | Q1 | -$0.05 | — | -$0.05 | — | $16.09M | — | $9.59M | — | Get Alert |
02/27/2023 | AM | PLX | Q4 | -$0.14 | -$0.15 | -$0.07 | 53.33% | $8.55M | $6.12M | $8.62M | 40.80% | Get Alert |
11/14/2022 | AM | PLX | Q3 | -$0.09 | -$0.15 | -$0.07 | 53.33% | $12.05M | $14.18M | $14.18M | 0.00% | Get Alert |
08/15/2022 | AM | PLX | Q2 | -$0.25 | -$0.18 | -$0.11 | 38.89% | $6.43M | — | $8.75M | — | Get Alert |
05/16/2022 | AM | PLX | Q1 | -$0.14 | -$0.05 | -$0.05 | 0.00% | $11.32M | $15.50M | $16.09M | 3.77% | Get Alert |
03/31/2022 | AM | PLX | Q4 | $0.03 | -$0.11 | -$0.14 | -27.27% | $19.50M | $7.79M | $8.55M | 9.74% | Get Alert |
11/15/2021 | AM | PLX | Q3 | -$0.14 | -$0.11 | -$0.09 | 18.18% | $10.79M | $7.79M | $12.05M | 54.74% | Get Alert |
08/16/2021 | AM | PLX | Q2 | -$0.13 | -$0.08 | -$0.25 | -212.50% | $10.97M | $8.30M | $6.43M | -22.57% | Get Alert |
05/14/2021 | AM | PLX | Q1 | $0.10 | -$0.17 | -$0.14 | 17.65% | $21.65M | $10.95M | $11.32M | 3.38% | Get Alert |
03/30/2021 | AM | PLX | Q4 | $0.02 | -$0.08 | $0.03 | 137.50% | $3.78M | $11.99M | $19.50M | 62.59% | Get Alert |
10/29/2020 | AM | PLX | Q3 | -$0.20 | -$0.17 | -$0.14 | 17.65% | $14.25M | $10.08M | $10.79M | 7.04% | Get Alert |
08/10/2020 | AM | PLX | Q2 | -$0.50 | -$0.20 | -$0.13 | 35.00% | $12.25M | $10.87M | $10.97M | 0.89% | Get Alert |
06/01/2020 | AM | PLX | Q1 | -$0.50 | -$0.30 | $0.10 | 133.33% | $10.44M | $6.60M | $21.65M | 227.97% | Get Alert |
03/12/2020 | AM | PLX | Q4 | -$0.30 | — | $0.02 | — | $10.35M | $12.85M | $3.78M | -70.58% | Get Alert |
11/07/2019 | AM | PLX | Q3 | -$0.40 | -$0.30 | -$0.20 | 33.33% | $663.00K | $11.60M | $14.25M | 22.83% | Get Alert |
Protalix BioTherapeutics (PLX) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on March 14, 2024 for Q4.
The Actual EPS was $-0.07, which missed the estimate of $-0.03.
The Actual Revenue was $10.5M, which beat the estimate of $5.8M.
Browse earnings estimates, EPS, and revenue on all stocks.